Vapotherm Inc (VAPO) Inventory Turnover Ratio, from second quarter 2024 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Vapotherm Inc   (VAPO)
 

Vapotherm Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Vapotherm Inc inventory turnover ratio, the Vapotherm Inc 's ability to sell and replace its inventory in the second quarter 2024, sequentially increased to 1.62 in the second quarter 2024, yet the ratio remained below the average, as VAPO's market remain challenging.Average inventory processing period, for the Vapotherm Inc in Jun 30 2024 quarter, has decreased to 225 days, compare to 227 days, in the Mar 31 2024 quarter.

Within Healthcare sector 267 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2024, to 1597, from total ranking in the first quarter 2024 at 1610.

VAPO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vapotherm Inc Market Share?

What is Inventory Turnover Ratio?




VAPO Inventory Turnover Ratio (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Inventory Growth -7.35 % -15.57 % -30.36 % -36.62 % -34.47 %
Y / Y Cost of Sales Growth -6.28 % -17.73 % -22.19 % -21.64 % -13.47 %
Inventory Turnover Ratio (TTM) 1.62 1.61 1.62 1.58 1.49
VAPO's Total Ranking # 1597 # 1610 # 1610 # 994 # 994
Average inventory processing period 226 227 225 231 245
Seq. Inventory Growth -3.19 % 4.77 % -0.54 % -8.16 % -11.77 %
Seq. Cost of Sales Growth -9.24 % -10.05 % 15.1 % -0.25 % -20.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 268
Overall Market # 1597

Inventory Turnover Ratio Statistics
High Average Low
3.45 2.02 0.28
(Dec 31 2020)   (Mar 31 2019)




Financial Statements
Vapotherm Inc 's Inventories $ 23 Millions Visit VAPO's Balance sheet
Vapotherm Inc 's Cost of Revenues TTM $ 38 Millions Visit VAPO's Income Statement
What are VAPO's Sales? Visit VAPO's Sales by Segment

Other Inventory Turnover Ratios
Vapotherm Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VAPO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VAPO's Competitors
Inventory Turnover Ratio for VAPO's Suppliers
Inventory Turnover Ratio for VAPO's Customers

You may also want to know
VAPO's Sales Growth Rates VAPO's Pe Price to earnings ratio VAPO's Receivables Turnover Ratio VAPO's Stock Quote
VAPO's Net Income Growth Rates VAPO's Ps Price to Sales ratio VAPO's Sales per Employee VAPO's Asset Turnover Ratio
VAPO's Net Margin VAPO's Pb Price to Book ratio VAPO's Financial Strength Ratios VAPO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
Precision Optics Corporation Inc   4.45 $ 13.307  Millions$ 3  Millions
Harrow Inc   4.44 $ 44.461  Millions$ 10  Millions
Adm Tronics Unlimited Inc   4.41 $ 1.748  Millions$ 0  Millions
Scilex Holding Company  4.39 $ 16.143  Millions$ 4  Millions
West Pharmaceutical Services Inc   4.31 $ 1,849.300  Millions$ 429  Millions
Escalon Medical Corp   4.31 $ 6.835  Millions$ 2  Millions
Envista Holdings Corporation  4.31 $ 1,150.700  Millions$ 267  Millions
Steris Plc  4.27 $ 3,085.440  Millions$ 722  Millions
Lifeward ltd   4.25 $ 15.819  Millions$ 4  Millions
Align Technology inc   4.20 $ 1,188.507  Millions$ 283  Millions
Electromedical Technologies Inc   4.18 $ 0.290  Millions$ 0  Millions
Ge Healthcare Technologies Inc   4.13 $ 8,356.000  Millions$ 2,025  Millions
Bristol myers Squibb Company  4.10 $ 11,450.000  Millions$ 2,790  Millions
Ufp Technologies Inc   4.10 $ 298.948  Millions$ 73  Millions
Integrated Biopharma Inc  4.08 $ 46.000  Millions$ 11  Millions
Organogenesis Holdings Inc   4.06 $ 112.420  Millions$ 28  Millions
Avid Bioservices Inc   4.02 $ 133.460  Millions$ 33  Millions
Blue Water Vaccines Inc  3.93 $ 2.301  Millions$ 1  Millions
Dynatronics Corporation  3.93 $ 24.899  Millions$ 6  Millions
Strata Skin Sciences Inc  3.90 $ 13.821  Millions$ 4  Millions
Idexx Laboratories Inc  3.88 $ 1,498.526  Millions$ 386  Millions
Exelixis Inc   3.78 $ 79.450  Millions$ 21  Millions
Incyte Corporation  3.76 $ 267.432  Millions$ 71  Millions
Catalyst Pharmaceuticals Inc   3.70 $ 57.901  Millions$ 16  Millions
Gilead Sciences Inc   3.68 $ 6,751.000  Millions$ 1,832  Millions
Teva Pharmaceutical Industries Limited  3.65 $ 8,227.000  Millions$ 2,256  Millions
3m Company  3.64 $ 17,158.000  Millions$ 4,711  Millions
Tactile Systems Technology Inc   3.62 $ 77.622  Millions$ 21  Millions
Lftd Partners Inc   3.59 $ 31.422  Millions$ 9  Millions
Becton Dickinson And Company  3.52 $ 11,488.000  Millions$ 3,265  Millions

Date modified: 2026-08-29T17:40:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.